Data investigation
Many People Never Reach the Dose
Only 58% of people starting semaglutide reached the recommended maintenance dose after four weeks, and 21% stayed on the starting dose. More than half of oral semaglutide starters stopped altogether.
There is a simple explanation for why real-world results look worse than trial results, and it is not that patients are different. A UK population study found that only 58% of people starting semaglutide reached the recommended maintenance dose after four weeks, and 21% were still on the starting dose, the one that exists to be tolerated rather than to work.[1]
Where people end up
By the tenth prescription, the commonest subcutaneous semaglutide doses were 0.5 mg (44.0%) and 1 mg (48.6%). The 2 mg dose was not prescribed in this database during the study period, so 1 mg was the top of the ladder these patients were on.[1] Nearly half were still a step below it after ten prescriptions, which is most of a year.
Escalation was faster in people with higher BMI, and the authors found no further variation by other patient characteristics, including established cardiovascular disease. Delayed escalation was, in their words, frequent across all patient stratifications.[1] The ladders themselves differ in length: Saxenda’s dose ladder is the shortest climb to a full dose among the GLP‑1 weight drugs, 0.6 mg a day raised by 0.6 mg each week to 3.0 mg in week five, where the others take months to reach their top dose.
A trial escalates on protocol. Ordinary care escalates when someone remembers to.
And half of them stop
| Drug | Discontinued |
|---|---|
| Dulaglutide | 36.9% |
| Semaglutide, subcutaneous | 46.4% |
| Semaglutide, oral | 55.8% |
More than half of the people who started the oral version stopped.[1] That is the formulation sold on convenience, yet it has the strictest daily conditions: an empty stomach on waking, then a wait before anything else (see travel and time zones). A convenient format does not make for a convenient routine.
The worst nausea in our side-effect ranking belonged to another oral drug, orforglipron. That says nothing directly about oral semaglutide.
Why this reframes so much else
We wrote recently that real-world data shows outcome differences by race and ethnicity where randomized trials showed none, and argued the gap lies in access, continuity and titration rather than in patients (see who responds in the real world). This study puts numbers on the titration half of that argument.
If a fifth of people are still on the starting dose when the first step up is due and nearly half stop altogether, then a large part of “the drug worked less well than in trials” is really “the drug was never taken at the dose it was tested at, for the duration it was tested for”. Those are different problems with different solutions. Stopping itself splits the same way: not tolerating a drug and not taking it reliably have different predictors.
What this does not establish
- It is a type 2 diabetes population in UK primary care. Dosing targets, prescribing incentives and follow-up patterns differ from US weight-management practice.
- It does not say why people stopped. Side effects, cost, supply and simply not returning are all in there, undifferentiated.
- Slow escalation is sometimes correct. Holding a dose because someone is nauseated is good medicine, not a failure, and the labels build that judgment in.
- Higher is not automatically better. For tirzepatide the step from 10 to 15 mg added little on average, as which Zepbound dose works best shows. The point is that most people never get the chance to find out.
Frequently Asked Questions
References
- 1.Ulrich FS, Napoli N, Nielsen MF, et al. Real-world persistence and dose titration of GLP-1 receptor agonists in type 2 diabetes: A UK population-based cohort study Diabetes, Obesity and Metabolism. 2026. PMID: 41703773.
Compare the sellers
Related research
Why Combination Therapy Fails in Practice
A pragmatic trial of combining two diabetes drugs found 53% filled the prescription against 84% on one drug, and half of those who filled later stopped one. The participants were insured.
5 min read
Every Other Week: Stretching the Interval
Patients moved to every-other-week dosing after a plateau held their weight and body composition over 36 weeks. It is a case series with no control group, and it is the third of three different ways to use less drug.
5 min read
Switching Between GLP-1 Drugs
No label contains a dose equivalence between semaglutide and tirzepatide, because no regulator has been asked to approve one. Every conversion chart online is somebody's arithmetic.
5 min read
A Pill to Hold What the Injection Lost
Daily oral orforglipron maintained 79.3% of weight already lost against 37.6% on placebo at a year in people coming off semaglutide, and 74.7% against 49.2% after tirzepatide. The trial had no arm that stayed on the injection, which is the question people actually have.
5 min read
GLP-1s, Travel and Time Zones
For a weekly injection, time zones barely matter: a week is 168 hours and an eight-hour shift is under 5% of it. The daily oral, anchored to waking rather than the clock, is the one that needs planning.
5 min read
BPC-157 Dosage: What the Human Studies Actually Gave
There is no approved BPC-157 dose. The five published human studies used enemas, knee or bladder injections and IV infusions, never the subcutaneous, oral or topical routes sold. Why rat µg/kg doses and dosage charts do not convert.
9 min read
Where to get GLP-1 online, safely: sellers our editors have checked
These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.
No insurance needed · vetted by our editors
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
MyDrHank
An oral route if you will not self-inject
From $171/mo, prepaid
Get started →YourEra
Semaglutide at $99/month, well below the typical price
From $99/mo
Get started →Eden
Coverage in all 50 states, which most sellers will not confirm
From $99/mo
Get started →